45 results
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
/transferred outside the ordinary course of business
Total payments to third parties incident to assets being sold/transferred outside the ordinary course
8-K
EX-99.3
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
/transferred outside the ordinary course of business
Total payments to third parties incident to assets being sold/transferred outside the ordinary
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
the ordinary course of business
Total payments to third parties incident to assets being sold/transferred outside the ordinary course of business
Net
8-K
EX-99.2
PHASQ
PhaseBio Pharmaceuticals Inc
29 Nov 23
Other Events
4:55pm
incident to assets being sold/transferred outside the ordinary course of business $0 $0 c. Net cash proceeds from assets sold/transferred outside
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
29 Nov 23
Other Events
4:55pm
a. Total cash sales price for assets sold/transferred outside the ordinary course of business $0 $36,644,483 b. Total payments to third parties incident
8-K
EX-99.1
29c40h4 j5s8b
27 Sep 23
Other Events
8:52am
8-K
EX-99.1
8dd m6br42uqdiab
25 Aug 23
Other Events
12:34pm
8-K
EX-99.2
m1kbjxwnc7 r5
25 Aug 23
Other Events
12:34pm
8-K
EX-99.1
0w6 0dpgnwc22
30 May 23
Other Events
4:02pm
8-K
EX-99.1
lnlk6x5
10 May 23
Other Events
8:08am
8-K
EX-99.1
x66ed6bh
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
8-K
EX-1.1
lsm9ds7qzkilu 76f5
19 Mar 21
PhaseBio Announces Pricing of Public Offering of Common Stock
4:08pm